ZNF322 and lung carcinoma: Our findings not only present a previously undefined regulatory mechanism by which ZNF322A synergizes KrasG12D-induced lung tumorigenesis but also indicate that dysregulation of YY1/ZNF322A transcriptional axis promotes expression of angiogenic factor Shh and cancer progression in lung cancer (Figure 6).